As the first line of antitumor defense in the body, NKs can release perforin on the surface of target cells, resulting in cell perforation, allowing granzyme b to enter tumor cells to induce apoptosis and thus non-specifically kill tumor cells. The gene discussed is PRF1; the disease is neoplasm.